188 related articles for article (PubMed ID: 17827441)
1. Cyclic nucleotide signaling mechanisms in trypanosomes: possible targets for therapeutic agents.
Laxman S; Beavo JA
Mol Interv; 2007 Aug; 7(4):203-15. PubMed ID: 17827441
[TBL] [Abstract][Full Text] [Related]
2. Trypanocidal drugs: mechanisms, resistance and new targets.
Wilkinson SR; Kelly JM
Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
[TBL] [Abstract][Full Text] [Related]
3. New messages from old messengers: cAMP and mycobacteria.
Shenoy AR; Visweswariah SS
Trends Microbiol; 2006 Dec; 14(12):543-50. PubMed ID: 17055275
[TBL] [Abstract][Full Text] [Related]
4. Drugs and drug resistance in African trypanosomiasis.
Delespaux V; de Koning HP
Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
[TBL] [Abstract][Full Text] [Related]
5. Structure, function and evolution of microbial adenylyl and guanylyl cyclases.
Baker DA; Kelly JM
Mol Microbiol; 2004 Jun; 52(5):1229-42. PubMed ID: 15165228
[TBL] [Abstract][Full Text] [Related]
6. Discrete intracellular signaling domains of soluble adenylyl cyclase: camps of cAMP?
Bundey RA; Insel PA
Sci STKE; 2004 Apr; 2004(231):pe19. PubMed ID: 15126677
[TBL] [Abstract][Full Text] [Related]
7. [Trypanosomiases].
Pelloux H; Aznar C; Bouteille B
Rev Prat; 2006 Dec; 56(20):2209-16. PubMed ID: 17352316
[TBL] [Abstract][Full Text] [Related]
8. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
9. Trypanosomes at the gates.
Cross GA
Science; 2005 Jul; 309(5733):355. PubMed ID: 16020696
[No Abstract] [Full Text] [Related]
10. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
de Koning HP
Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
[TBL] [Abstract][Full Text] [Related]
11. Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions.
Rodriguez-Soca Y; Munteanu CR; Dorado J; Pazos A; Prado-Prado FJ; González-Díaz H
J Proteome Res; 2010 Feb; 9(2):1182-90. PubMed ID: 19947655
[TBL] [Abstract][Full Text] [Related]
12. Molecular tools for the rapid detection of drug resistance in animal trypanosomes.
Delespaux V; Geysen D; Van den Bossche P; Geerts S
Trends Parasitol; 2008 May; 24(5):236-42. PubMed ID: 18420457
[TBL] [Abstract][Full Text] [Related]
13. Cyclic-nucleotide signalling in protozoa.
Gould MK; de Koning HP
FEMS Microbiol Rev; 2011 May; 35(3):515-41. PubMed ID: 21223322
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP signalling pathways in the regulation of uterine relaxation.
Yuan W; López Bernal A
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S10. PubMed ID: 17570154
[TBL] [Abstract][Full Text] [Related]
15. Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke.
Carod-Artal FJ
Expert Rev Cardiovasc Ther; 2010 May; 8(5):717-28. PubMed ID: 20450304
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP effectors in African trypanosomes revealed by genome-scale RNA interference library screening for resistance to the phosphodiesterase inhibitor CpdA.
Gould MK; Bachmaier S; Ali JA; Alsford S; Tagoe DN; Munday JC; Schnaufer AC; Horn D; Boshart M; de Koning HP
Antimicrob Agents Chemother; 2013 Oct; 57(10):4882-93. PubMed ID: 23877697
[TBL] [Abstract][Full Text] [Related]
17. High-resolution measurements of cyclic adenosine monophosphate signals in 3D microdomains.
Karpen JW; Rich TC
Methods Mol Biol; 2005; 307():15-26. PubMed ID: 15988052
[TBL] [Abstract][Full Text] [Related]
18. Novel antitrypanosomal agents.
Steverding D; Tyler KM
Expert Opin Investig Drugs; 2005 Aug; 14(8):939-55. PubMed ID: 16050789
[TBL] [Abstract][Full Text] [Related]
19. New developments in human African trypanosomiasis.
Brun R; Balmer O
Curr Opin Infect Dis; 2006 Oct; 19(5):415-20. PubMed ID: 16940863
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
